Top Abstract Purchase Related
Home
>
Node
>
Subnode

Possible antiarrhythmic activities of trapidil

Sakanashi, M.; Yoshikawa, Y.; Akiyoshi, R.; Itoh, C.; Kitamura, Y.; Niho, T.; Ohnishi, H.

Arzneimittel-Forschung 33(2): 215-217

1983

ISSN/ISBN: 0004-4172
PMID: 6682660
Document Number: 207114
Possible antiarrhythmic activities of 5-methyl-7-diethylamino-s-triazolo(1,5-a)pyrimidine (trapidil, Rocornal) were investigated in vitro and in vivo. Trapidil significantly increased the amount of aconitine or ouabain needed for production of ventricular arrhythmias in rats and guinea pigs. Trapidil also produced a significant increase in threshold current of electrical stimuli which induced ventricular tachycardia in dogs under acute myocardial ischemia. Electrophysiological examinations on effects of trapidil on isolated rabbit ventricular muscle cells showed shortening of the action potential duration (APD) and prolongation of the effective refractory period (ERP), resulting in an increase in the ratio of ERP/APD. The results indicate that trapidil will have a possible effectiveness in inhibiting ventricular arrhythmias.

Document emailed within 1 workday
Secure & encrypted payments

Riedel, A.; Schneider, S.; Mest, H.J. 1987: The effectiveness of trapidil and trapidil derivatives on drug-induced heart arrhythmias in the rat and guinea pig Arzneimittel-Forschung 37(8): 923-926
Heinroth-Hoffmann, I.; Hauser, A.; Taube, C.; Mest, H.J. 1988: Effects of trapidil and trapidil derivatives on arachidonic acid and prostaglandin endoperoxide analogue U 46619-induced blood pressure changes in rats Biomedica Biochimica Acta 47(10-11): S145-S148
Longobardi, M.; Bargagna, A.; Mariani, E.; Schenone, P.; Vitagliano, S.; Stella, L.; Di Sarno, A.; Marmo, E. 1990: 2H-[1]benzothiepino [5,4-b]pyran derivatives with local anesthetic and antiarrhythmic activities Farmaco 45(4): 399-404
Saini, R.K.; Antonaccio, M.J. 1982: Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 221(1): 29-36
Chen, C.L.; Sangiah, S.; Patterson, E.; Berlin, K.D.; Garrison, G.L.; Dunn, W.; Nan, Y.; Scherlag, B.J.; Lazzara, R. 1992: Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force Research Communications in Chemical Pathology and Pharmacology 78(1): 3-16
Nawada, T.; Tanaka, Y.; Hirai, S.; Hisatome, I.; Hasegawa, J.; Kotake, H.; Mashiba, H. 1994: Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs International Journal of Clinical Pharmacology and Therapeutics 32(7): 347-355
Ernest, K. 1975: Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters Polish Journal of Pharmacology and Pharmacy 27(4): 381-398
Ranise, A.; Bruno, O.; Schenone, S.; Bondavalli, F.; Falcone, G.; Filippelli, W.; Sorrentino, S. 1997: Synthesis of 6-thiosubstituted 5-ethoxycarbonyl-1,3-diphenyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-ones, 6-substituted 5-hydroxy-1,3-diphenyl-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-ones and their esters with local anesthetic, antiarrhythmic, antiinflammatory and analgesic activities Farmaco 52(8-9): 547-555
Pease, R.W. 1987: Antiarrhythmic versus antidysrhythmic: antiarrhythmic is preferable American Journal of Hospital Pharmacy 44(8): 1776
Mest, H.J.; Thomas, E. 1986: Is there a renaissance for trapidil? Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(8): 217-220
Bornschein, I.; Wierer, A.; Borchert, H.H.; Pfeifer, S. 1976: Biotransformation of trapidil (Rocornal) Die Pharmazie 31(1): 51
Bornschein, M.; Grohmann, A.; Hackenberger, F.; Grune, D. 1981: The bioavailability of trapidil from suppositories Die Pharmazie 36(12): 830-832
Sakanashi, M.; Takeo, S.; Miyamoto, Y.; Higuchi, M. 1982: Relaxant effect of trapidil on isolated dog bronchus Archives Internationales de Pharmacodynamie et de Therapie 259(1): 134-143
Gehrke, A.; Leidreiter, B.; Bornschein, I. 1976: The serum protein binding of trapidil (Rocornal) Die Pharmazie 31(8): 579-580
Block, H.U.; Heinroth, I.; Giessler, C.; Pönicke, K.; Mentz, P.; Zehl, U.; Rettkowski, W.; Dunemann, A.; Förster, W. 1983: The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal) Biomedica Biochimica Acta 42(2-3): 283-299
Bongrani, S.; Schiantarelli, P.; Razzetti, R.; Papotti, M. 1987: Analysis of effects induced by trapidil on the respiratory system and pulmonary circulation. Experimental research Cardiologia 32(9): 1053-1057
Serruys; Banz; Darcis; Mignot; van Es GA; Schwicker 1997: Results of a Meta-Analysis of Trapidil, a PDGF Inhibitor Ñ a Sufficient Reason for a Second look to the Pharmacological Approach to Restenosis Journal of Invasive Cardiology 9(8): 505-512
Mazurov, A.V.; Leĭtin, V.L.; Repin, V.S. 1984: Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil Voprosy Meditsinskoi Khimii 30(4): 110-116
Voigt, H.; Reuter, W.; Hofmann, B.; Dobberkau, A. 1990: Oral trapidil treatment of Fontaine stage Ii arteriosclerotic circulatory disorders of the legs--a double-blind study Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 45(10): 283-287
Fukuda, M.; Yoshimoto, H.; Matsuyama, S.; Hirata, Y.; Watanabe, I.; Ichikawa, H.; Fukami, K.; Itoi, M.; Manabe, R.; Matsuo, N. 1986: Clinical utility of trapidil (MDR-1865) in treating diabetic retinopathy--a multicenter, placebo-controlled, double-blind study Nippon Ganka Gakkai Zasshi 90(12): 1532-1549